Breaking News

Texcell Doubles Capacity for Biosafety Testing and Viral Clearance Studies

GLP facility offers the opportunity to execute scaled-down manufacturing models, or have the work transferred to a dedicated viral clearance team.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Texcell – North America, Inc., part of the Texcell Group of global biosafety contract research organizations, broke ground for a new facility in Frederick, MD. The expansion is a next step in Texcell’s growth trajectory as they increase capabilities for all their service lines, including customized R&D cell culture, GLP viral clearance studies, and select GMP assay capabilities for viral safety testing. The multimillion-dollar facility will add 27,000 sq.-ft. of lab and office space, m...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters